References:
- Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III) final report. Circulation 2002;106:3143-421.
- Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol
2008; 28: 629-36.
- Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic
syndrome: a global public health problem and a new deinition. J
Atheroscler Thromb 2005; 12: 295- 300.
- Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K: Colorectal cancer
mortality and factors related to the insulin resistance syndrome.
Cancer Epidemiol Biomarkers Prev 2002, 11:385–391.
- Hammarsten and Peeker R. Nat Rev Urol. Urological aspects of the
metabolic syndrome. 2011; 8 : 483-94
- Gorbachinsky et al. Rev Urol. Metabolic syndrome and urological
diseases. 2010; 12 : 157-80
- Chu et al. Postgrad Med. The impact of obesity on benign and malignant
urologic conditions 2013; 125 : 53-69
- Motzer Rj, Agarwal N, Beard C, et al. Kidney cancer clinical practice
guidelines in oncology. J Natl Compr CAnc Netw 9:960-977,2011
- Campbell SC, Lane BR. Malignant renal tumors. In: Kavoussu LR, Novick
AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 10th ed.
Philedelphia: Saunders 2012; 1413.
- Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for
cancer? Am J Pathol 2006;169:1505-22.
- Choi Y, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, et al. Body mass
index and survival in patients with renal cell carcinoma: A
clinical-based cohort and meta-analysis. Int J Cancer 2013 Feb
1;132(3):625-34
- Lipworth L, Tarone RE, Lund L, McLaughlin JK. Epidemiologic
characteristics and risk factors for renal cell cancer. Clin Epidemiol
2009;1:33-43.
- Navai N, Wood CG. Environmental and modifiable risk factors in renal
cell carcinoma. Urol Oncol 2012;30:220-4.
- Robson CJ. Staging of renal cell carcinoma. Prog Clin Biol Res.
1982;100:439-45.
- Edge SB, American Joint Committee on Cancer. AJCC cancer staging
manual. Eighth edition. ed. xvii, 1,024 pages p
- Atan A. Metabesity and urological cancers. Turk J Urol. 2017
Dec;43(4):410-413. doi: 10.5152/tud.2017.66502. Epub 2017 Dec 1.
Review.
- Zucchetto A, Dal Maso L, Tavani A ve ark. History of treated
hypertension and diabetes mellitus and risk of renal cell cancer. Ann
Oncol 2007; 18: 596-600.
- Hajdu SI, Thomas AG (1967) Renal cell carcinoma at autopsy. J Urol 97:
978±982
- Whisenand JM, Kostas D, Sommers SC (1962) Some Host Factors in the
Development of Renal Cell Carcinoma. West J Surg Gynecol 70: 284±285
- Lindblad P, Chow WH, Chan J, et al. The role of diabetes mellitus in
the aetiology of renal cell cancer. Diabetologia 1999, 42:107–112.
- Joh HK, Willett WC, Cho E: Type 2 diabetes and the risk of renal cell
cancer in women. Diabetes Care 2011, 34:1552–1556.
- Lee H, Kwak C, Kim HH, et al. Diabetes mellitus as an independent
predictor of survival of patients surgically treated for renal cell
carcinoma: A propensity score matching study. J Urol. 194:1554–1560.
2015.
- Fukushima H, Masuda H, Yokoyama M, et al. Diabetes mellitus with
obesity is a predictor of recurrence in patients with non-metastatic
renal cell carcinoma. Jpn J Clin Oncol. 43:740–746. 2013.
- Otunctemur A, Ozbek E, Sahin S, et al. Diabetes mellitus as a risk
factor for high grade renal cell carcinoma. Asian Pac J Cancer Prev.
2014;15(9):3993-6
- Li M, Liu J, Hu WL, et al. Effect of metformin on apoptosis of renal
cell carcinoma cells in vitro and its mechanisms. Nan Fang Yi Ke Da
Xue Xue Bao 2011, 31:1504–1508.
- Liu J, Li M, Song B, et al. Metformin inhibits renal cell carcinoma in
vitro and in vivo xenograft. Urol Oncol 2013, 31:264–270.
- Habib SL, Prihoda TJ, Luna M, Werner SA (2012). Diabetes and risk of
renal cell carcinoma. J Cancer , 3, 42-8.
- Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B: Obesity, hypertension,
and the risk of kidney cancer in men. N Engl J Med 2000,
343:1305–1311.
- Colt JS, Schwartz K, Graubard BI,et al. : Hypertension and risk of
renal cell carcinoma among white and black Americans. Epidemiology
2011, 22:797–804.
- Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell
carcinoma. J Urol. 2006 Dec;176(6 Pt 1):2353-8.
- Grossman E, Messerli FH, Goldbourt U: Does diuretic therapy increase
the risk of renal cell carcinoma? Am J Cardiol 1999, 83:1090–1093
- Wulaningsih W, Garmo H, Holmberg L,et al. Serum Lipids and the Risk of
Gastrointestinal Malignancies in the Swedish AMORIS Study. J Cancer
Epidemiol 2012, 2012:792034.
- Inoue M, Noda M, Kurahashi N, et al.Impact of metabolic factors on
subsequent cancer risk: results from a large-scale population-based
cohort study in Japan. Eur J Cancer Prev 2009, 18:240–247.
- Horiguchi A, Ito K, Sumitomo M, et al. Decreased serum adiponectin
levels in patients with metastatic renal cell carcinoma. Jpn J Clin
Oncol 2008, 38:106–111.
- Drabkin HA, Gemmill RM (2012) Cholesterol and the development of
clear-cell renal carcinoma. Curr Opin Pharmacol 12(6):742–750
- Eichholzer M, Stahelin HB, Gutzwiller F, et al. (2000). Association of
low plasma cholesterol with mortality for cancer at various sites in
men: 17-y follow-up of the prospective Basel study. Am J Clin
Nutr , 71, 569-74.
- Bowers K, Albanes D, Limburg P, et al (2006). A prospective study of
anthropometric and clinical measurements associated with insulin
resistance syndrome and colorectal cancer in male smokers. Am J
Epidemiol , 164, 652-64.
- Meilahn EN, Ferrell RE. ‘Naturally occurring’ low blood cholesterol
and excess mortality. Coron Artery Dis 1993;4:843–53.
- Bjørge T, Tretli S, Engeland A. Relation of height and body mass index
to renal cell carcinoma in two million Norwegian men and women. Am J
Epidemiol. 2004 Dec 15;160(12):1168-76.
- Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal
cell carcinoma in the European Prospective Investigation into Cancer
and Nutrition (EPIC). Int J Cancer. 2006 Feb 1;118(3):728-38.
- Haggstrom C, Rapp K, Stocks T et al. Metabolic factors associated with
risk of renal cell carcinoma. PLoS One 2013;8:e57475.
- Leiba A, Kark JD, Afek Adolescent obesity and paternal country of
origin predict renal cell carcinoma: a cohort study of 1.1 million 16
to 19-year-old males. J Urol 2013, 189:25–29.
- Parker AS, Lohse CM, Cheville JC, et al (2006). Greater body mass
index is associated with better pathologic features and improved
outcome among patients treated surgically for clear cell renal cell
carcinoma. Urol , 68, 741.